Relevance of airflow obstruction and mucus hypersecretion to mortality
- PMID: 2014356
- DOI: 10.1016/s0954-6111(06)80207-6
Relevance of airflow obstruction and mucus hypersecretion to mortality
Abstract
A group of 2,065 gold miners surveyed between 1968 and 1970 was followed to 31 December 1986, at which date 859 were known to be dead. The relationship between airways obstruction and mucus hypersecretion to causes of mortality was analyzed. Airways obstruction was strongly related to mortality from chronic obstructive pulmonary disease (COPD), lung cancer, coronary heart disease and other causes. After standardization for airways obstruction, mucus hypersecretion was not related to mortality from COPD but remained related to mortality from ischaemic heart disease (IDH) and other causes, even after adjustment for tobacco smoking and dust exposure. Mucus hypersecretion was not related to mortality from lung cancer when standardized for airways obstruction.
Similar articles
-
The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation.Am Rev Respir Dis. 1983 Sep;128(3):491-500. doi: 10.1164/arrd.1983.128.3.491. Am Rev Respir Dis. 1983. PMID: 6614643
-
Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.Thorax. 1990 Aug;45(8):579-85. doi: 10.1136/thx.45.8.579. Thorax. 1990. PMID: 2402719 Free PMC article.
-
The value of mucus hypersecretion as a predictor of mortality and hospitalization. An 11-year register based follow-up study of a random population sample of 876 men.Respir Med. 1989 May;83(3):207-11. doi: 10.1016/s0954-6111(89)80033-2. Respir Med. 1989. PMID: 2595038
-
Mucus hypersecretion in chronic obstructive pulmonary disease.Novartis Found Symp. 2001;234:65-77; discussion 77-83. doi: 10.1002/0470868678.ch5. Novartis Found Symp. 2001. PMID: 11199104 Review.
-
Epidemiology of bronchial hypersecretion: recent studies.Eur J Respir Dis Suppl. 1987;153:13-8. Eur J Respir Dis Suppl. 1987. PMID: 3322856 Review.
Cited by
-
Systematic review with meta-analysis of the epidemiological evidence relating FEV1 decline to lung cancer risk.BMC Cancer. 2012 Oct 27;12:498. doi: 10.1186/1471-2407-12-498. BMC Cancer. 2012. PMID: 23101666 Free PMC article. Review.
-
Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines.Chest. 2006 Jan;129(1 Suppl):104S-115S. doi: 10.1378/chest.129.1_suppl.104S. Chest. 2006. PMID: 16428699 Free PMC article. Review.
-
Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence.Occup Environ Med. 2003 Apr;60(4):237-43. doi: 10.1136/oem.60.4.237. Occup Environ Med. 2003. PMID: 12660371 Free PMC article. Review.
-
Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis.Respir Res. 2005 Aug 25;6(1):98. doi: 10.1186/1465-9921-6-98. Respir Res. 2005. PMID: 16120227 Free PMC article. Clinical Trial.
-
Impact of productive and dry chronic cough on mortality in the Canadian Longitudinal Study on Aging (CLSA).J Thorac Dis. 2022 Dec;14(12):5087-5096. doi: 10.21037/jtd-22-1306. J Thorac Dis. 2022. PMID: 36647475 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
